Designing cell lines for viral vaccine production: Where do we stand? (Q38436738)

3 September 2017

title

Designing cell lines for viral vaccine production: Where do we stand? (English)

1 reference

3 September 2017

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903999%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Yvonne Genzel

series ordinal

1

1 reference

3 September 2017

publication date

22 April 2015

1 reference

3 September 2017

language of work or name

English

0 references

published in

Biotechnology Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903999%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903999%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903999%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

728-740

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903999%20AND%20SRC:MED&resulttype=core&format=json

publication type of scholarly work

10 June 2020

review article

1 reference

describes a project that uses

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

Development of new cell lines for animal cell biotechnology

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Cloning and Sequencing of the Cellular–Viral Junctions from the Human Adenovirus Type 5 Transformed 293 Cell Line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Overview of measles and mumps vaccine: origin, present, and future of vaccine production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

From gene switches to mammalian designer cells: present and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

An avian cell line designed for production of highly attenuated viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Safety of MDCK Cell Culture-Based Influenza Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

An MDCK cell culture-derived formalin-inactivated influenza virus whole-virion vaccine from an influenza virus library confers cross-protective immunity by intranasal administration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Establishment of Shrimp Cell Lines: Perception and Orientation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

A new approach to establish a cell line with reduced risk of endogenous retroviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

New Directions in Nicotine Vaccine Design and Use

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Human cells: new platform for recombinant therapeutic protein production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Cell immortalization: the role of viral genes and carcinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Eternity and functionality – rational access to physiologically relevant cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

The common mechanisms of transformation by the small DNA tumor viruses: The inactivation of tumor suppressor gene products: p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Immortalized chick embryo cell line adapted to serum-free growth conditions and capable of replicating human and reassortant H5N1 influenza strains for vaccine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

N-methyl-N'-nitro-N-nitrosoguanidine-induced senescence-like growth arrest in colon cancer cells is associated with loss of adenomatous polyposis coli protein, microtubule organization, and telomeric DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Vaccine production: upstream processing with adherent or suspension cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

A single‐use purification process for the production of a monoclonal antibody produced in a PER.C6 human cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

A genotype of modified vaccinia Ankara (MVA) that facilitates replication in suspension cultures in chemically defined medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Poxvirus entry and membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Susceptibility of the PER.C6 cell line for infection with clinical human respiratory syncytial virus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Establishment of higher passage PER.C6 cells for adenovirus manufacture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

CAP, a new human suspension cell line for influenza virus production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Comparison of initial feasibility of host cell lines for viral vaccine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

A chemically defined production process for highly attenuated poxviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

The avian cell line AGE1.CR.pIX characterized by metabolic flux analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

EB66 cell line, a duck embryonic stem cell-derived substrate for the industrial production of therapeutic monoclonal antibodies with enhanced ADCC activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Establishment of an immortal chicken embryo liver-derived cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

A Novel Strategy To Develop a Robust Infectious Hepatitis C Virus Cell Culture System Directly from a Clinical Isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Novel permissive cell lines for complete propagation of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Generation of a permanent cell line that supports efficient growth of Marek's disease virus (MDV) by constitutive expression of MDV glycoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Vaccines for fish in aquaculture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Development of a mandarin fish Siniperca chuatsi fry cell line suitable for the study of infectious spleen and kidney necrosis virus (ISKNV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Comparison of betanodavirus replication efficiency in ten Indian fish cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Isolation of salmon pancreas disease virus (SPDV) in cell culture and its ability to protect against infection by the 'wild-type' agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Toward metabolic engineering in the context of system biology and synthetic biology: advances and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Characteristics of a human diploid cell designated MRC-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Challenges in Manufacturing Adenoviral Vectors for Global Vaccine Product Deployment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

PER.C6(®) cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

Propagation of viruses infecting waterfowl on continuous cell lines of Muscovy duck (Cairina moschata) origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400388

21 January 2018

Identifiers

DOI

10.1002/BIOT.201400388

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25903999%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference